Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk
- PMID: 26168013
- PMCID: PMC4930791
- DOI: 10.1038/ng.3353
Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk
Abstract
Variation in the human leukocyte antigen (HLA) genes accounts for one-half of the genetic risk in type 1 diabetes (T1D). Amino acid changes in the HLA-DR and HLA-DQ molecules mediate most of the risk, but extensive linkage disequilibrium complicates the localization of independent effects. Using 18,832 case-control samples, we localized the signal to 3 amino acid positions in HLA-DQ and HLA-DR. HLA-DQβ1 position 57 (previously known; P = 1 × 10(-1,355)) by itself explained 15.2% of the total phenotypic variance. Independent effects at HLA-DRβ1 positions 13 (P = 1 × 10(-721)) and 71 (P = 1 × 10(-95)) increased the proportion of variance explained to 26.9%. The three positions together explained 90% of the phenotypic variance in the HLA-DRB1-HLA-DQA1-HLA-DQB1 locus. Additionally, we observed significant interactions for 11 of 21 pairs of common HLA-DRB1-HLA-DQA1-HLA-DQB1 haplotypes (P = 1.6 × 10(-64)). HLA-DRβ1 positions 13 and 71 implicate the P4 pocket in the antigen-binding groove, thus pointing to another critical protein structure for T1D risk, in addition to the HLA-DQ P9 pocket.
Conflict of interest statement
The authors declare no competing financial interests.
Figures






Similar articles
-
The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DRβ1 and HLA-DQβ1 molecules on risk of Iranian type 1 diabetes mellitus patients.Int J Immunogenet. 2012 Oct;39(5):429-36. doi: 10.1111/j.1744-313X.2012.01116.x. Epub 2012 Apr 12. Int J Immunogenet. 2012. PMID: 22494469
-
Association of HLA-DRB1 and -DQ Alleles and Haplotypes with Type 1 Diabetes in Jordanians.Endocr Metab Immune Disord Drug Targets. 2020;20(6):895-902. doi: 10.2174/1871530319666191119114031. Endocr Metab Immune Disord Drug Targets. 2020. PMID: 31742498
-
HLA-DRB, -DQA, and DQB alleles and haplotypes in Iranian patients with diabetes mellitus type I.Pediatr Diabetes. 2013 Aug;14(5):366-71. doi: 10.1111/j.1399-5448.2012.00869.x. Epub 2012 May 14. Pediatr Diabetes. 2013. PMID: 22583516
-
The association of human leukocyte antigen class II (HLA II) haplotypes with the risk of Latent autoimmune diabetes of adults (LADA): Evidence based on available data.Gene. 2021 Jan 30;767:145177. doi: 10.1016/j.gene.2020.145177. Epub 2020 Sep 28. Gene. 2021. PMID: 32998048 Review.
-
Genetic markers for insulin-dependent diabetes mellitus in Japanese.Diabetes Res Clin Pract. 1994 Oct;24 Suppl:S83-7. doi: 10.1016/0168-8227(94)90232-1. Diabetes Res Clin Pract. 1994. PMID: 7859639 Review.
Cited by
-
Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset.Front Immunol. 2024 Aug 9;15:1427349. doi: 10.3389/fimmu.2024.1427349. eCollection 2024. Front Immunol. 2024. PMID: 39185409 Free PMC article.
-
Blood donor biobank as a resource in personalised biomedical genetic research.Eur J Hum Genet. 2024 Jan 12. doi: 10.1038/s41431-023-01528-0. Online ahead of print. Eur J Hum Genet. 2024. PMID: 38212662
-
Fifty years of HLA-associated type 1 diabetes risk: history, current knowledge, and future directions.Front Immunol. 2024 Sep 12;15:1457213. doi: 10.3389/fimmu.2024.1457213. eCollection 2024. Front Immunol. 2024. PMID: 39328411 Free PMC article. Review.
-
Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1.Sci Rep. 2022 Mar 11;12(1):4266. doi: 10.1038/s41598-022-07997-5. Sci Rep. 2022. PMID: 35277540 Free PMC article. Clinical Trial.
-
Association between alleles, haplotypes, and amino acid variations in HLA class II genes and type 1 diabetes in Kuwaiti children.Front Immunol. 2023 Aug 10;14:1238269. doi: 10.3389/fimmu.2023.1238269. eCollection 2023. Front Immunol. 2023. PMID: 37638053 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- U01 DK062418/DK/NIDDK NIH HHS/United States
- 5R01AR062886-02/AR/NIAMS NIH HHS/United States
- UH2 AR067677/AR/NIAMS NIH HHS/United States
- R01 AR065183/AR/NIAMS NIH HHS/United States
- 100140/WT_/Wellcome Trust/United Kingdom
- 1UH2AR067677-01/AR/NIAMS NIH HHS/United States
- 1R01AR063759/AR/NIAMS NIH HHS/United States
- 5U01GM092691-05/GM/NIGMS NIH HHS/United States
- RG/08/014/24067/BHF_/British Heart Foundation/United Kingdom
- DH_/Department of Health/United Kingdom
- R01AR065183/AR/NIAMS NIH HHS/United States
- MR/L003120/1/MRC_/Medical Research Council/United Kingdom
- U01 GM092691/GM/NIGMS NIH HHS/United States
- R01 AR063759/AR/NIAMS NIH HHS/United States
- R01 AR062886/AR/NIAMS NIH HHS/United States
- 091157/WT_/Wellcome Trust/United Kingdom
- U01DK062418/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials